<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dhakal P</submitter><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>311-321</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8819600</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(3)</volume><pubmed_abstract>&lt;b>Background:&lt;/b> We used the Therapy Preference Scale, a 30-item questionnaire, to determine cancer treatment preferences of adults with cancer. &lt;b>Methods:&lt;/b> We used Wilcoxon's rank sum test and Fisher's exact test to compare the preferences of younger (&lt;60 years) versus older adults (≥60 years). &lt;b>Results:&lt;/b> While 56% of patients would accept treatment offering increased life expectancy at an expense of short-term side effects, 75% preferred maintenance of cognition, functional ability and quality of life to quantity of days. Oral instead of intravenous treatment (p = 0.003), shorter hospital stay (p = 0.03), preservation of cognitive function (p = 0.01) and avoidance of pain (p = 0.02) were more important to older patients compared with younger patients. &lt;b>Conclusion:&lt;/b> Many patients prioritized maintenance of cognition, functional ability and quality of life; older patients valued oral treatment, shorter hospital stay, preservation of cognitive function and avoidance of pain.</pubmed_abstract><journal>Future oncology (London, England)</journal><pubmed_title>Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?</pubmed_title><pmcid>PMC8819600</pmcid><funding_grant_id>GM115458</funding_grant_id><funding_grant_id>U54 GM115458</funding_grant_id><pubmed_authors>Wichman CS</pubmed_authors><pubmed_authors>Pozehl B</pubmed_authors><pubmed_authors>Bociek RG</pubmed_authors><pubmed_authors>Bhatt VR</pubmed_authors><pubmed_authors>Dhakal P</pubmed_authors><pubmed_authors>Vose J</pubmed_authors><pubmed_authors>Weaver M</pubmed_authors><pubmed_authors>Fisher AL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?</name><description>&lt;b>Background:&lt;/b> We used the Therapy Preference Scale, a 30-item questionnaire, to determine cancer treatment preferences of adults with cancer. &lt;b>Methods:&lt;/b> We used Wilcoxon's rank sum test and Fisher's exact test to compare the preferences of younger (&lt;60 years) versus older adults (≥60 years). &lt;b>Results:&lt;/b> While 56% of patients would accept treatment offering increased life expectancy at an expense of short-term side effects, 75% preferred maintenance of cognition, functional ability and quality of life to quantity of days. Oral instead of intravenous treatment (p = 0.003), shorter hospital stay (p = 0.03), preservation of cognitive function (p = 0.01) and avoidance of pain (p = 0.02) were more important to older patients compared with younger patients. &lt;b>Conclusion:&lt;/b> Many patients prioritized maintenance of cognition, functional ability and quality of life; older patients valued oral treatment, shorter hospital stay, preservation of cognitive function and avoidance of pain.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-19T18:08:00.649Z</modification><creation>2025-04-19T18:08:00.649Z</creation></dates><accession>S-EPMC8819600</accession><cross_references><pubmed>34761681</pubmed><doi>10.2217/fon-2021-0260</doi></cross_references></HashMap>